Displaying 1–4 of 4 results for Justin O. Neway, Ph.D., Aegis Analytical Corp
In a recent talk, Ajaz Hussain, former FDA Deputy Director of the Office of Pharmaceutical Science (OPS), reminisces about the Agency's 21st Century initiative and looks ahead to challenges yet to be addressed.
The draft guidance is a win-win-win: good for FDA, consumers, and manufacturers.
Implementing a new IT paradigm for on-demand data is as much an organizational issue as it is a technological one.
Critical to any PAT effort is having a single point of easy, on-demand access to all relevant data, in a context thats meaningful to diverse groups of users. But data must be presented in a way that facilitates the identification and understanding of cause-and-effect relationships. Justin Neway,...